Resected EGFR -mutated non-small-cell lung cancers: incidence and outcomes in a European population (GFPC Exerpos Study).

MLA

Auliac, Jean-Bernard, et al. “Resected EGFR -Mutated Non-Small-Cell Lung Cancers: Incidence and Outcomes in a European Population (GFPC Exerpos Study).” Therapeutic Advances in Medical Oncology, Mar. 2024, pp. 1–10. EBSCOhost, https://doi.org/10.1177/17588359241236451.

APA

Auliac, J.-B., Thomas, P.-A., Bylicki, O., Guisier, F., Curcio, H., AlainVegnenègre, Swalduz, A., Wislez, M., Le Treut, J., Decroisette, C., Basse, V., Falchero, L., De Chabot, G., Moreau, D., Huchot, E., Lupo Mansuet, A., Blons, H., Chouaïd, C., & Greillier, L. (2024). Resected EGFR -mutated non-small-cell lung cancers: incidence and outcomes in a European population (GFPC Exerpos Study). Therapeutic Advances in Medical Oncology, 1–10. https://doi.org/10.1177/17588359241236451

Chicago

Auliac, Jean-Bernard, Pascal-Alexandre Thomas, Olivier Bylicki, Florian Guisier, Hubert Curcio, AlainVegnenègre, Aurelie Swalduz, et al. 2024. “Resected EGFR -Mutated Non-Small-Cell Lung Cancers: Incidence and Outcomes in a European Population (GFPC Exerpos Study).” Therapeutic Advances in Medical Oncology, March, 1–10. doi:10.1177/17588359241236451.